Garnet Biotherapeutics

BiotechnologySeries AMalvern, USgarnetbio.com

Latest round

Series A

Last raised

Jan 2009

Total raised

$13M

Investors

4

About Garnet Biotherapeutics

Garnet Biotherapeutics is a biotechnology company focused on advancing innovative therapies for challenging medical conditions.Founded in 1999, Garnet Biotherapeutics operates out of Malvern, US, specializing in biotherapeutic solutions.Garnet Biotherapeutics focuses on developing innovative therapies for various medical conditions, leveraging advanced biotherapeutic technologies.4 mn to expand its research initiatives and develop new therapeutic products. The company is targeting to enter additional markets by 2025, focusing on North America and Europe to broaden its reach and impact in the biotherapeutic space.

Who invested in Garnet Biotherapeutics

4 investors across 2 rounds

See all investors in Garnet Biotherapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 29, 2009

    Amount

    $10M

    Investors

    Locked

  2. Series D

    Feb 24, 2006

    Amount

    $2.7M

    Investors

    Locked

Questions about Garnet Biotherapeutics

Who invested in Garnet Biotherapeutics?

Garnet Biotherapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Garnet Biotherapeutics raised?

Garnet Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Garnet Biotherapeutics last raise money?

Garnet Biotherapeutics's most recent round on record is a Series A, in Jan 2009.

What does Garnet Biotherapeutics do?

Garnet Biotherapeutics is a biotechnology company focused on advancing innovative therapies for challenging medical conditions.

Where is Garnet Biotherapeutics headquartered?

Garnet Biotherapeutics is headquartered in Malvern, US.

Which VCs invest in companies like Garnet Biotherapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Garnet Biotherapeutics's stage. Their profiles are linked below.

Raising like Garnet Biotherapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.